Page last updated: 2024-08-25

alantolactone and Disease Exacerbation

alantolactone has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dai, T; Hao, X; Jiang, N; Sang, M; Sun, X; Sun, Y; Wang, X; Xie, L; Xu, H; Zhao, Q	1

Other Studies

1 other study(ies) available for alantolactone and Disease Exacerbation

Article	Year
Alantolactone inhibits cervical cancer progression by downregulating BMI1. Scientific reports, 2021, 04-29, Volume: 11, Issue:1 Topics: Animals; Apoptosis; Autophagy; Biomarkers, Tumor; Cell Cycle; Cell Movement; Cell Proliferation; Disease Progression; Epithelial-Mesenchymal Transition; Female; Humans; Lactones; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Neoplasm Invasiveness; Polycomb Repressive Complex 1; Sesquiterpenes, Eudesmane; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2021

Article

Year

Alantolactone inhibits cervical cancer progression by downregulating BMI1.

Scientific reports, 2021, 04-29, Volume: 11, Issue:1

Topics: Animals; Apoptosis; Autophagy; Biomarkers, Tumor; Cell Cycle; Cell Movement; Cell Proliferation; Disease Progression; Epithelial-Mesenchymal Transition; Female; Humans; Lactones; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Neoplasm Invasiveness; Polycomb Repressive Complex 1; Sesquiterpenes, Eudesmane; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2021